Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 6785852, 9 pages
https://doi.org/10.1155/2017/6785852
Research Article

Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant Proteins

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA

Correspondence should be addressed to Kota V. Ramana; ude.bmtu@anamarvk

Received 31 March 2017; Revised 15 May 2017; Accepted 28 May 2017; Published 27 June 2017

Academic Editor: Hao Wu

Copyright © 2017 Kirtikar Shukla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Geraldes, J. Hiraoka-Yamamoto, M. Matsumoto et al., “Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy,” Nature Medicine, vol. 15, no. 11, pp. 1298–1306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Busik, S. Mohr, and M. B. Grant, “Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators,” Diabetes, vol. 57, no. 7, pp. 1952–1965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Srivastava, K. V. Ramana, and A. Bhatnagar, “Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options,” Endocrine Reviews, vol. 26, no. 3, pp. 380–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. V. Ramana, “Aldose reductase: new insights for an old enzyme,” Biomolecular Concepts, vol. 2, no. 1-2, 2011. View at Google Scholar
  5. K. V. Ramana and S. K. Srivastava, “Aldose reductase: a novel therapeutic target for inflammatory pathologies,” The International Journal of Biochemistry & Cell Biology, vol. 42, no. 1, pp. 17–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. V. Ramana, “Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 277, no. 35, pp. 32063–32070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. K. V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S. K. Srivastava, “Activation of nulcear factor-B by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase,” Diabetes, vol. 53, no. 11, pp. 2910–2920, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Srivastava, K. V. Ramana, R. Tammali, S. K. Srivastava, and A. Bhatnagar, “Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells,” Diabetes, vol. 55, no. 4, pp. 901–910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Nguyen, P. Nioi, and C. B. Pickett, “The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291–13295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Ma, “Role of Nrf2 in oxidative stress and toxicity,” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, pp. 401–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Tammali, A. Saxena, S. K. Srivastava, and K. V. Ramana, “Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells,” Journal of Biological Chemistry, vol. 286, no. 27, pp. 24089–24100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava, “Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells,” Diabetes, vol. 54, no. 3, pp. 818–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Shoeb, U. C. S. Yadav, S. K. Srivastava, and K. V. Ramana, “Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages,” Free Radical Biology and Medicine, vol. 51, no. 9, pp. 1686–1696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Srivastava, U. C. S. Yadav, A. B. M. Reddy et al., “Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders,” Chemico-Biological Interactions, vol. 191, no. 1–3, pp. 330–338, 2011. View at Google Scholar
  15. S. Pandey, S. K. Srivastava, and K. V. Ramana, “A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases,” Expert Opinion on Investigational Drugs, vol. 21, no. 3, pp. 329–339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. W. H. Tang, K. A. Martin, and J. Hwa, “Aldose reductase, oxidative stress, and diabetic mellitus,” Frontiers in Pharmacology, vol. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. de Haan, “Nrf2 activators as attractive therapeutics for diabetic nephropathy,” Diabetes, vol. 60, no. 11, pp. 2683-2684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Li, S. Liu, L. Miao, and L. Cai, “Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy,” Experimental Diabetes Research, vol. 2012, pp. 1–7, 2012. View at Google Scholar
  19. K. Liby, “The synthetic triterpenoids, CDDO and CDDO-Imidazolide, are potent inducers of Heme oxygenase-1 and Nrf2/ARE signaling,” Cancer Research, vol. 65, no. 11, pp. 4789–4798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. K. Thimmulappa, R. J. Fuchs, D. Malhotra et al., “Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils,” Antioxidants & Redox Signaling, vol. 9, no. 11, pp. 1963–1970, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. P. W. Wong, G. Wells, and T. Hagen, “Heteroaromatic 4-arylquinols are novel inducers of nuclear factor-erythroid 2-related factor 2 (Nrf2),” European Journal of Pharmacology, vol. 643, no. 2-3, pp. 188–194, 2010. View at Google Scholar
  22. H. Li, L. Zhang, F. Wang et al., “Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation,” American Journal of Nephrology, vol. 33, no. 4, pp. 289–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yang, G. Chen, X. Cheng et al., “Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect,” Scientific Reports, vol. 5, no. 1, 2015. View at Google Scholar
  24. T. Jiang, Z. Huang, Y. Lin, Z. Zhang, D. Fang, and D. D. Zhang, “The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy,” Diabetes, vol. 59, no. 4, pp. 850–860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Xue, Q. Qian, A. Adaikalakoteswari, N. Rabbani, R. Babaei-Jadidi, and P. J. Thornalley, “Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease,” Diabetes, vol. 57, no. 10, pp. 2809–2817, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Bai, X. Wang, S. Zhao, C. Ma, J. Cui, and Y. Zheng, “Sulforaphane protects against cardiovascular disease via Nrf2 activation,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. GHorbani, A. Hekmatdoost, and P. Mirmiran, “Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin,” International Journal of Endocrinology and Metabolism, vol. 12, no. 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Masuda, N. D. Vaziri, S. Li et al., “The effect of Nrf2 pathway activation on human pancreatic islet cells,” PLoS One, vol. 10, no. 6, p. e0131012, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Zhang, M. Fu, S. H. Gao, and J. L. Liu, “Curcumin and diabetes: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–16, 2013. View at Google Scholar
  30. E. Kang, G. Kim, H. Kim et al., “Nrf2 regulates curcumin-induced aldose reductase expression indirectly via nuclear factor-κB,” Pharmacological Research, vol. 58, no. 1, pp. 15–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Negi, V. Nakkina, P. Kamble, and S. S. Sharma, “Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy,” Pharmacological Research, vol. 102, pp. 158–167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Á. F. Castilho, C. A. Aveleira, E. C. Leal et al., “Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity,” PLoS One, vol. 7, no. 8, p. e42428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Li, D. H. Kim, P. L. Tsenovoy et al., “Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance,” Diabetes, vol. 57, no. 6, pp. 1526–1535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Saad, H. Ibrahim, W. Nazmy, and A. Hussein, “Induction of heme oxygenase-1 improves glucose tolerance and enhances insulin sensitivity in obese diabetic rats,” Journal of Advances in Medical and Pharmaceutical Sciences, vol. 10, no. 3, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  35. M. S. Joo, W. D. Kim, K. Y. Lee, J. H. Kim, J. H. Koo, and S. G. Kim, “AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550,” Molecular and Cellular Biology, vol. 36, no. 14, pp. 1931–1942, 2016. View at Publisher · View at Google Scholar · View at Scopus